Repetitive transcranial magnetic stimulation for smoking cessation

Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive brain stimulation technique used for treating mental health disorders, including smoking addiction. A new rTMS device with a novel coil design, Hcoil, has been approved for smoking cessation by the US FDA and Health Canada. The de...

Full description

Saved in:
Bibliographic Details
Published in:Canadian Medical Association journal (CMAJ) 2024-02, Vol.196 (6), p.E187-E190
Main Authors: Ibrahim, Christine, Tang, Victor M, Blumberger, Daniel M, Le Foll, Bernard
Format: Article
Language:English
Subjects:
Abstinence
Addictions
Alcohol
Brain research
Care and treatment
Clinical trials
Clinics
Convulsions & seizures
Design
Drug therapy
FDA approval
Humans
Magnetic brain stimulation
Methods
Patients
Prefrontal Cortex - physiology
Schizophrenia
Smoking
Smoking Cessation
Smoking cessation programs
Substance abuse
Transcranial Magnetic Stimulation
Treatment Outcome
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive brain stimulation technique used for treating mental health disorders, including smoking addiction. A new rTMS device with a novel coil design, Hcoil, has been approved for smoking cessation by the US FDA and Health Canada. The device generates magnetic fields to produce electrical currents in targeted brain areas, facilitating changes in brain activity. Treatment is delivered at a clinic by trained staff and consists of 15 daily sessions over 3 weeks, followed by 1 weekly session for 3 weeks. The evidence supporting the use of rTMS for smoking cessation is promising, with higher abstinence rates compared to pharmacotherapy options. However, rTMS may not be suitable as a first-line therapy due to cost and in-person visit requirements. Future research should focus on real-world patient outcomes, cost-effectiveness, and the potential for combining rTMS with pharmacotherapies.
ISSN:0820-3946
1488-2329
1488-2329
DOI:10.1503/cmaj.230806